Abstract
Objectives
White matter hyperintensities (WMHs) are implicated in the etiology of dementia. The underlying pathology of WMHs involves myelin and axonal loss due to chronic ischemia. We investigated myelin loss in WMHs and normal-appearing white matter (NAWM) in patients with various degrees of cognitive impairment using quantitative synthetic magnetic resonance imaging (MRI).
Methods
We studied 99 consecutive patients with cognitive complaints who underwent 3 T brain MRI between July 2016 and August 2017. Myelin partial volume maps were generated with synthetic MRI. Region-of-interest–based analysis was performed on these maps to compare the myelin partial volumes of NAWM and periventricular and deep WMHs. The effects of myelin partial volume of NAWMs on clinical cognitive function were evaluated using multivariate linear regression analysis.
Results
WMHs were present in 30.3% of patients. Myelin partial volume in NAWM was lower in patients with WMHs than in those without (37.5 ± 2.7% vs. 39.9 ± 2.4%, p < 0.001). In patients with WMHs, myelin partial volume was highest in NAWMs (median [interquartile range], 37.2% [35.5–39.0%]), followed by deep WMHs (7.2% [3.2–10.5%]) and periventricular WMHs (2.1% [1.1–3.9%], p < 0.001). After adjusting for sex and education years, myelin partial volume in NAWMs was associated with the Clinical Dementia Rating Scale Sum of Box (β = -0.189 [95% CI, -0.380 to -0.012], p = 0.031).
Conclusion
Myelin loss occurs in both NAWM and WMHs of cognitively impaired patients. Synthetic MRI-based myelin quantification may be a useful imaging marker of cognitive dysfunction in patients with cognitive complaints.
Key Points
• Quantitative synthetic MRI allows simultaneous acquisition of conventional MRI and myelin quantification without additional scanning time.
• Normal-appearing and hyperintense white matter demonstrate myelin loss in cognitively impaired patients.
• This myelin loss partially explains cognitive dysfunction in patients with cognitive complaints.
Similar content being viewed by others
Abbreviations
- CDR-SB:
-
Clinical Dementia Rating Scale Sum of Boxes
- GMF:
-
Gray matter fraction
- ICV:
-
Intracranial volume
- MMSE:
-
Mini-Mental Status Examination
- NAWM:
-
Normal-appearing white matter
- WMF:
-
White matter fraction
- WMHs:
-
White matter hyperintensities
References
de Leeuw FE, de Groot JC, Achten E et al (2001) Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70:9–14
Debette S, Markus HS (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341:c3666
Prins ND, Scheltens P (2015) White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 11:157–165
Gouw AA, Seewann A, van der Flier WM et al (2011) Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 82:126–135
Fernando MS, O'Brien JT, Perry RH et al (2004) Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 30:385–395
Bronge L, Bogdanovic N, Wahlund LO (2002) Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement Geriatr Cogn Disord 13:205–212
Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25:5–18 author reply 49-62
Dean DC 3rd, Hurley SA, Kecskemeti SR et al (2017) Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease. JAMA Neurol 74:41–49
Fazekas F, Ropele S, Enzinger C et al (2005) MTI of white matter hyperintensities. Brain 128:2926–2932
O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC, Markus HS (2001) Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 57:2307–2310
Kavroulakis E, Simos PG, Kalaitzakis G et al (2018) Myelin content changes in probable Alzheimer's disease and mild cognitive impairment: associations with age and severity of neuropsychiatric impairment. J Magn Reson Imaging 47:1359–1372
Warntjes JB, Leinhard OD, West J, Lundberg P (2008) Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 60:320–329
Wardlaw JM, Smith EE, Biessels GJ et al (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12:822–838
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149:351–356
Hagiwara A, Warntjes M, Hori M et al (2017) SyMRI of the brain: rapid quantification of relaxation rates and proton density, with synthetic MRI, automatic brain segmentation, and myelin measurement. Invest Radiol 52:647–657
Warntjes M, Engström M, Tisell A, Lundberg P (2016) Modeling the presence of myelin and edema in the brain based on multi-parametric quantitative MRI. Front Neurol 7:16
West J, Warntjes JB, Lundberg P (2012) Novel whole brain segmentation and volume estimation using quantitative MRI. Eur Radiol 22:998–1007
Pantoni L, Simoni M (2003) Pathophysiology of cerebral small vessels in vascular cognitive impairment. Int Psychogeriatr 15(Suppl 1):59–65
Fazekas F, Kleinert R, Offenbacher H et al (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43:1683–1689
Simpson JE, Ince PG, Higham CE et al (2007) Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol 33:670–683
Maillard P, Fletcher E, Harvey D et al (2011) White matter hyperintensity penumbra. Stroke 42:1917–1922
Vavasour IM, Laule C, Li DK, Traboulsee AL, MacKay AL (2011) Is the magnetization transfer ratio a marker for myelin in multiple sclerosis? J Magn Reson Imaging 33:713–718
Firbank MJ, Minett T, O'Brien JT (2003) Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects. Neurology 61:950–954
Grueter BE, Schulz UG (2012) Age-related cerebral white matter disease (leukoaraiosis): a review. Postgrad Med J 88:79–87
Erten-Lyons D, Woltjer R, Kaye J et al (2013) Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology 81:977–983
Muñoz Maniega S, Chappell FM, Valdés Hernández MC et al (2017) Integrity of normal-appearing white matter: influence of age, visible lesion burden and hypertension in patients with small-vessel disease. J Cereb Blood Flow Metab 37:644–656
Gouw AA, Seewann A, Vrenken H et al (2008) Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 131:3286–3298
Wharton SB, Simpson JE, Brayne C, Ince PG (2015) Age-associated white matter lesions: the MRC cognitive function and ageing study. Brain Pathol 25:35–43
O'Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, Markus HS (2004) Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 75:441–447
Snaidero N, Simons M (2014) Myelination at a glance. J Cell Sci 127:2999–3004
Sun J, Zhou H, Bai F, Zhang Z, Ren Q (2017) Remyelination: a potential therapeutic strategy for Alzheimer's disease? J Alzheimers Dis 58:597–612
Cha MY, Kwon YW, Ahn HS et al (2017) Protein-induced pluripotent stem cells ameliorate cognitive dysfunction and reduce Abeta deposition in a mouse model of Alzheimer's disease. Stem Cells Transl Med 6:293–305
Piao J, Major T, Auyeung G et al (2015) Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. Cell Stem Cell 16:198–210
Alonso-Ortiz E, Levesque IR, Pike GB (2015) MRI-based myelin water imaging: a technical review. Magn Reson Med 73:70–81
O'Bryant SE, Waring SC, Cullum CM et al (2008) Staging dementia using clinical dementia rating scale sum of boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol 65:1091–1095
Acknowledgments
This research was presented as a scientific exhibit at the ECR 2018 (C-1637) and awarded a Certificate of Merit.
Funding
This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no.2017R1A2B4010634) and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI18C1038).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Won-Jin Moon.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• Retrospective
• Cross-sectional study
• Performed at one institution
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 10194 kb)
Rights and permissions
About this article
Cite this article
Park, M., Moon, Y., Han, SH. et al. Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study. Eur Radiol 29, 4914–4921 (2019). https://doi.org/10.1007/s00330-018-5836-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-018-5836-x